首页> 外文期刊>Bone marrow transplantation >Philadelphia-positive T-ALL in a patient with follicular lymphoma.
【24h】

Philadelphia-positive T-ALL in a patient with follicular lymphoma.

机译:滤泡性淋巴瘤患者的费城阳性T-ALL。

获取原文
获取原文并翻译 | 示例
           

摘要

Follicular lymphoma is a B cell malignancy prone to transformation into a large cell diffuse histology. This progression may be multi-clonal as determined by IgH rearrangement. Similar multi-clonal occurrences have been described in immunocompromised patients. However, the lymphoma cells remain predominantly of B cell type. Rarely, composite lymphomas with diffuse T cell histology have been reported arising from follicular lymphoma. The development of T cell leukaemia in a patient with a pre-existing B cell malignancy is an extremely rare event. The occurrence of T cell acute lymphoblastic leukaemia (T-ALL) following follicular lymphoma (FL) has not previously been reported. We report a case of Philadelphia positive (Ph+) T cell ALL developing in a patient who previously had FL which may give some insight into the cell of origin and the defects responsible for malignant transformation of the lymphocytes.
机译:滤泡性淋巴瘤是一种易于转化为大细胞弥漫性组织学的B细胞恶性肿瘤。如IgH重排所确定的,该进展可能是多克隆的。在免疫功能低下的患者中已经描述了类似的多克隆事件。然而,淋巴瘤细胞仍然主要是B细胞类型。很少有滤泡性淋巴瘤引起具有弥漫性T细胞组织学的复合淋巴瘤。既往患有B细胞恶性肿瘤的患者中T细胞白血病的发生是极为罕见的事件。滤泡性淋巴瘤(FL)之后,T细胞急性淋巴细胞白血病(T-ALL)的发生尚未见报道。我们报道了一例先前患有FL的患者发生的费城阳性(Ph +)T细胞ALL的病例,这可能使您对起源细胞和导致淋巴细胞恶变的缺陷有所了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号